High expression of UBD correlates with epirubicin resistance and indicates poor prognosis in triple-negative breast cancer

Xiaodong Xie, TAO HAN, Yaling Han, Wanqing Xie, Ranran Zhang, Li Zhu, Zhaozhe Liu, Fang Guo, Hengyu Li, Yuan Sheng
  • OncoTargets and Therapy, July 2015, Dove Medical Press
  • DOI: 10.2147/ott.s81214

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication

http://dx.doi.org/10.2147/ott.s81214

The following have contributed to this page: Dr Tao Han and Guo Fang Guo